- Display 30 Products per page
Published: September 8, 2023 | Price: $5,000.00 – $10,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: April 3, 2023 | Price: $5,000.00 – $10,000.00
The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027 focuses on the market for single cell genomics products. Analyzed are the hardware, service of the hardware, software, and consumables included for the sequencing step and other types of downstream analysis. Single cell RNA-seq enables new types of analyses, for instance: understanding tumour heterogeneity and clonal evolution (including studying lineage analysis, cancer stem cells, and drug-resistant and metastatic clones), understanding complex tissues (e.g. neural tissues), high resolution...Published: December 29, 2022 | Price: $6,000.00 – $12,000.00
Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year. Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to...Published: September 7, 2022 | Price: $0.00 – $9,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: August 29, 2022 | Price: $7,500.00
This report, produced by Bioinformatics Inc. (not part of Kalorama subscriptions) is a recent survey of 350 respondents from North America, Europe and Asia Pacific that use social media and/or science-related websites for personal or professional purposes participated in this study Readers of this study will understand: Understand the technologies used for isolation of single cells in 2022 Evaluate the kit and instrument suppliers used for single cell experiments Understand the pain points currently experienced with single cell experiments and areas...Published: May 5, 2022 | Price: $6,000.00 – $12,000.00
Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products -- the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market. The competitive situation, deals, and products are covered in respective chapters. Historical data for...Published: January 6, 2022 | Price: $5,000.00 – $10,000.00
This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market for Multi-Analyte-based Liquid Biopsy The Market for Other Liquid Biopsy Liquid Biopsy Market by Type...Published: July 28, 2021 | Price: $4,000.00 – $8,000.00
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing This report, Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2021-2026 and NGS sample preparation revenues by geographic region for 2020 (North America, Europe, Asia-Pacific, rest-of-world). The introduction of smaller, cheaper benchtop NGS systems has expanded the market into smaller labs that could never afford prices for earlier...Published: December 23, 2020 | Price: $5,500.00 – $11,000.00
The study of individual cells has long been an important part of biological research. Historically this has been a very manual process; some automated technologies are available. The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved. The ability to amplify DNA or RNA from an individual cell was a key development. As a result of continuous technological advances in the last 15 years, the use of...Published: August 24, 2020 | Price: $5,500.00 – $11,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: August 2, 2019 | Price: $6,000.00 – $12,000.00
Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next-Generation Sequencing Markets provides an in-depth look at the sequencing market, including data for 2018-2023...Published: May 30, 2019 | Price: $5,500.00 – $11,000.00
Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid...Published: September 7, 2018 | Price: $4,500.00 – $9,000.00
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2017-2022 and NGS sample preparation revenues by geographic region for 2017 (North America, Europe, Asia-Pacific, rest-of-world). As NGS science continues to evolve, the report examines trends in the market, including the gradual acceptance and validation of clinical applications, China becoming...Published: May 4, 2018 | Price: $4,500.00 – $9,000.00
Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) analyzes the current and potential world market for single use systems for upstream bioprocessing. This report generally reviews the nature and direction of research, as well as future markets. Market forecasts cover various segments from 2016-2021, including global revenues for single use upstream processing;...Published: February 5, 2018 | Price: $3,995.00 – $8,400.00
The Market and Potential for CRISPR/Cas9 Gene Editing This report consolidates the information and trends and provides reliable market estimates for CRISPR technology to 2023. As part of the report's coverage, it provides the following: Market Size and Forecast for CRISPR/Cas9 Gene Editing, 2017-2023 The Market for CRISPR/Cas9 by Region (N. Amer. EU, ROW), 2017-2023 Analysis of Growth Trend by Region Market by Application (Cancer Research, Non-Cancer Disease Research, Cancer Diagnostics, Infection Diagnostics, Plant, Food, Biofuel, Drug Discovery, Drug Development,...Published: January 3, 2017 | Price: $3,600.00 – $7,200.00
The Market for Mass Spectrometry in Clinical Testing Applications The Market for Mass Spectrometry in Clinical Testing Applications covers the global opportunity for mass spectrometry instruments and consumables, including mass spectrometry revenues for 2016 and 2021, regional markets for 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market), and mass spectrometry revenues by manufacturer for 2016 (%). The report provides revenue analysis and company activity in the market, such as mergers and agreements. Agilent, SCIEX, and Thermo...Published: April 27, 2016 | Price: $3,360.00 – $6,720.00
The Market for Sample Preparation for Next Generation Sequencing (NGS) The Market for Sample Preparation for Next Generation Sequencing (NGS) covers trends, challenges, strategies, manufacturers, and products, and provides estimates of revenue share and market growth, which includes NGS hardware and consumables. Data presented include NGS sample preparation market and growth rate, 2015-2020; market by geographic region, 2015 (North America, Europe, Asia-Pacific, rest-of-world); market by product type, 2015 (enrichment, libr prep kits panels, etc.; automation/ hardware; nucleic acid extraction; total);...Published: December 10, 2015 | Price: $1,396.50 – $2,793.00
The Global Market for Biomarkers (Cancer Biomarkers, Cardiovascular Disease Biomarkers, Immunological Disease Biomarkers, Infectious Disease Biomarkers, Neurological Disease Biomarkers, Novel Biomarkers for Other Diseases) The Global Market for Biomarkers analyzes the current and future markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers: The Market for Cancer Biomarkers The Market for Cardiovascular Disease Biomarkers The Market for Immunological Disease Biomarkers The Market for Infectious Disease Biomarkers The Market for Neurological Disease Biomarkers The...Published: June 19, 2015 | Price: $4,200.00 – $8,400.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) have tremendous utility in cancer research, aiding researchers in deciphering the complex processes leading to cancer metastasis and in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of cancer, as current tools, such as tumor tissue biopsy or imaging technologies, have numerous limitations. Although their biology and characteristics are...Published: December 23, 2014 | Price: $995.00 – $1,990.00
In the past, cancer treatments could be painful, invasive and damage the patient's body. Now there are many novel techniques available for cancer patients that are not as invasive and detrimental to the body as a whole. Gene therapy is the most prominent new form of these alternative treatments. This report, The Market for Personalized Gene Therapy Treatments For Cancer provides a complete review of the market potential for relatively new approach in cancer research, that of changing...Published: October 9, 2014 | Price: $995.00 – $7,990.00
Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products. Kalorama Information’s Stem Cell Therapeutics Markets is a complete analysis of stem cell drugs now and in development. The report estimates the opportunity by for novel technologies through an assessment of current products, pipeline, cost trends and regulation. Bottom-up and Top-Down analysis was used to determine market size and market forecasts. Over the next several years, as researchers introduce a growing variety...Published: October 16, 2013 | Price: $3,995.00 – $7,990.00
The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease. With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced. An example is creatine kinase,...Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...Published: January 1, 2012 | Price: $1,995.00 – $3,990.00
There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....Published: April 1, 2010 | Price: $2,995.00 – $5,990.00
This report combines two of Kalorama's latest research volumes DNA Sequencing and SNP Genotyping and Analysis Markets into one package, and includes a preface on the complementary/competitive use of SNP Analysis and whole-genome sequencing on topics and the impact of the results of GWAS on the market.Published: February 1, 2010 | Price: $1,995.00 – $4,000.00
Because SNPs are the most common type of genetic variation between human beings, these specific single base pair mutations can be ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and Kalorama has followed...Published: February 1, 2009 | Price: $995.00 – $5,000.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...Published: June 1, 2008 | Price: $1,995.00 – $7,990.00
SNPs (single nucleotide polymorphisms), single base pair mutations that occur at a specific site in the DNA sequence, are the most common type of genetic variation between human beings. Because they are responsible for over 80% of the variation between two individuals, SNPs are ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics...Published: March 1, 2008 | Price: $995.00 – $7,800.00
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug...Published: January 1, 2006 | Price: $2,995.00 – $5,990.00
The field of biotechnology instrumentation has been an expanding one ever since the emergence of the Human Genome Project 20 years ago. Although the filed certainly existed prior to that point in time, it was the Human Genome Project with its major access to key universities, national laboratories, and government funding sources that gave great acceleration to the field. There are several technologies applicable to genomic and proteomic analysis, all of which have become important to the nature of the...